Apolipoprotein A-II plus lipid emulsion enhance cell growth via SR-B1 and target pancreatic cancer in vitro and in vivo

PLoS ONE

Volumn 11, Issue 3, 2016, Pages

  Julovi, Sohel M ^a   Xue, Aiqun ^a   Thanh Le, Thao N ^a   Gill, Anthony J ^c   Bulanadi, Jerikho C ^a,d   Patel, Mili ^e   Waddington, Lynne J ^d   Rye, Kerry Anne ^e   Moghaddam, Minoo J ^d   Smith, Ross C ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d CSIRO   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A2; HIGH DENSITY LIPOPROTEIN; LIPID EMULSION; RECOMBINANT PROTEIN; SCAVENGER RECEPTOR BI; LIPID; SCARB1 PROTEIN, HUMAN; SCAVENGER RECEPTOR B;

ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FLUORESCENCE IMAGING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LIPID TRANSPORT; MOUSE; NONHUMAN; PANCREAS ADENOCARCINOMA; PANCREATIC CANCER CELL LINE; PROTEIN EXPRESSION; TRANSMISSION ELECTRON MICROSCOPY; TUMOR XENOGRAFT; WESTERN BLOTTING; CELL PROLIFERATION; MCF-7 CELL LINE; METABOLISM; PANCREAS CARCINOMA; PANCREAS TUMOR; PHYSIOLOGY; TUMOR CELL LINE;

APOLIPOPROTEIN A-II; CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; LIPIDS; LIPOPROTEINS, HDL; MCF-7 CELLS; PANCREATIC NEOPLASMS; SCAVENGER RECEPTORS, CLASS B;

EID: 84962406689     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0151475     Document Type: Article

References (51)

1. Xue A, Scarlett CJ, Chung L, Butturini G, Scarpa A, Gandy R, et al. Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis. Br J Cancer. 2010 Jul 27; 103(3): 391-400. doi: 10.1038/sj.bjc.6605764 PMID: 20588270
2. Honda K, Okusaka T, Felix K, Nakamori S, Sata N, Nagai H, et al. Altered plasmaapolipoprotein modifications in patients with pancreatic cancer: protein characterization and multi-institutional validation. PLoS One. 2012; 7(10): e46908. doi: 10.1371/journal.pone.0046908 PMID: 23056525
3. Felix K, Hauck O, Fritz S, Hinz U, Schnolzer M, Kempf T, et al. Serum protein signatures differentiating autoimmune pancreatitis versus pancreatic cancer. PLoS One. 2013; 8(12): e82755. doi: 10.1371/journal.pone.0082755 PMID: 24349355
4. Fan Y, Li F, Chen D. Scavenger receptor-recognized and enzyme-responsive nanoprobe for fluorescent labeling of lysosomes in live cells. Biomaterials. 2014 Sep; 35(27): 7870-80. doi: 10.1016/j.biomaterials.2014.05.054 PMID: 24929616
5. Silver DL, Wang N, Xiao X, Tall AR. High density lipoprotein (HDL) particle uptake mediated by scavenger receptor class Btype 1 results in selective sorting of HDL cholesterol from protein and polarized cholesterol secretion. J Biol Chem. 2001 Jul 6; 276(27): 25287-93. PMID: 11301333
6. Rodrigueza WV, Thuahnai ST, Temel RE, Lund-Katz S, Phillips MC, Williams DL. Mechanism of scavenger receptor class B type I-mediated selective uptake of cholesteryl esters from high density lipoprotein to adrenal cells. J Biol Chem. 1999 Jul 16; 274(29): 20344-50. PMID: 10400657
7. Thuahnai ST, Lund-Katz S, Dhanasekaran P, de la Llera-Moya M, Connelly MA, Williams DL, et al. Scavenger receptor class B type I-mediated cholesteryl ester-selective uptake and efflux of unesterified cholesterol. Influence of high density lipoprotein size and structure. J Biol Chem. 2004 Mar 26; 279 (13): 12448-55. PMID: 14718538
8. Shahzad MM, Mangala LS, Han HD, Lu C, Bottsford-Miller J, Nishimura M, et al. Targeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticles. Neoplasia. 2011 Apr; 13(4): 309-19. PMID: 21472135
9. Valacchi G, Sticozzi C, Lim Y, Pecorelli A. Scavenger receptorclass B type I: a multifunctional receptor. Ann NY Acad Sci. 2011 Jul; 1229: E1-7. doi: 10.1111/j.1749-6632.2011.06205.x PMID: 22239457
10. Connelly MA, Williams DL. SR-BI and cholesterol uptake into steroidogenic cells. Trends Endocrinol Metab. 2003 Dec; 14(10): 467-72. PMID: 14643062
11. Gospodarowicz D, Lui GM, Gonzalez R. High-density lipoproteins and the proliferation of human tumor cells maintained on extracellular matrix-coated dishes and exposed to defined medium. Cancer Res. 1982 Sep; 42(9): 3704-13. PMID: 7049362
12. Gao X, Yuan S, Jayaraman S, Gursky O. Role of apolipoprotein A-II in the structure and remodeling of human high-density lipoprotein (HDL): protein conformational ensemble on HDL. Biochemistry. 2012 Jun 12; 51(23): 4633-41. doi: 10.1021/bi300555d PMID: 22631438
13. Weng W, Brandenburg NA, Zhong S, Halkias J, Wu L, Jiang XC, et al. ApoA-II maintains HDL levels in part by inhibition of hepatic lipase. Studies In apoA-II and hepatic lipase double knockout mice. J Lipid Res. 1999 Jun; 40(6): 1064-70. PMID: 10357838
14. Huang H, Cruz W, Chen J, Zheng G. Learning from biology: synthetic lipoproteins for drug delivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2015 May-Jun; 7(3): 298-314. doi: 10.1002/wnan.1308 PMID: 25346461
15. de Beer MC, Durbin DM, Cai L, Mirocha N, Jonas A, Webb NR, et al. Apolipoprotein A-II modulates the binding and selective lipid uptake of reconstituted high density lipoprotein by scavenger receptor BI. J Biol Chem. 2001 May 11; 276(19): 15832-9. PMID: 11279034
16. Twiddy AL, Cox ME, Wasan KM. Knockdown of scavenger receptor class B type I reduces prostate specific antigen secretion and viability of prostate cancer cells. Prostate. 2012 Jun 15; 72(9): 955-65. doi: 10.1002/pros.21499 PMID: 22025344
17. Cao WM, Murao K, Imachi H, Yu X, Abe H, Yamauchi A, et al. A mutant high-density lipoprotein receptor inhibits proliferation of human breast cancer cells. Cancer Res. 2004 Feb 15; 64(4): 1515-21. PMID: 14973113
18. Czernin J, Phelps ME. Positron emission tomography scanning: current and future applications. Annu Rev Med. 2002; 53: 89-112. PMID: 11818465
19. Calderon P, Furnelle J, Christophe J. In vitro lipid metabolism in the rat pancreas. I. Basal lipid metabolism. Biochim Biophys Acta. 1979 Sep 28; 574(3): 379-90. PMID: 486517
20. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011 Mar 4; 144(5): 646-74. doi: 10.1016/j.cell.2011.02.013 PMID: 21376230
21. Biswas S, Lunec J, Bartlett K. Non-glucose metabolism in cancer cells - is it all in the fat? Cancer Metastasis Rev. 2012 Dec; 31(3-4): 689-98. doi: 10.1007/s10555-012-9384-6 PMID: 22706846
22. Warburg O. On the origin of cancer cells. Science. 1956 Feb 24; 123(3191): 309-14. PMID: 13298683
23. Ho YK, Smith RG, Brown MS, Goldstein JL. Low-density lipoprotein (LDL) receptor activity in human acute myelogenous leukemia cells. Blood. 1978 Dec; 52(6): 1099-114. PMID: 214187
24. Vitols S, Angelin B, Ericsson S, Gahrton G, Juliusson G, Masquelier M, et al. Uptake of low density lipoproteins by human leukemic cells in vivo: relation to plasma lipoprotein levels and possible relevance for selective chemotherapy. Proc Natl Acad Sci USA. 1990 Apr; 87(7): 2598-602. PMID: 2320578
25. Siperstein MD Role of cholesterogenesis and isoprenoid synthesis in DNA replication and cell growth. J Lipid Res. 1984 Dec 15; 25(13): 1462-8. PMID: 6397554
26. Pussinen PJ, Karten B, Wintersperger A, Reicher H, McLean M, Malle E, et al. The human breast carcinoma cell line HBL-100 acquires exogenous cholesterol from high-density lipoprotein via CLA-1 (CD-36 and LIMPII analogous 1)-mediated selective cholesteryl ester uptake. Biochem J. 2000 Jul 15; 349 (Pt 2): 559-66. PMID: 10880355
27. Imachi H, Murao K, Sayo Y, Hosokawa H, Sato M, Niimi M, et al. Evidence for a potential role for HDL as an important source of cholesterol in human adrenocortical tumors via the CLA-1 pathway. Endocr J. 1999 Feb; 46(1): 27-34. PMID: 10426565
28. Leon CG, Locke JA, Adomat HH, Etinger SL, Twiddy AL, Neumann RD, et al. Alterations in cholesterol regulation contribute to the production of intratumoral and rogens during progression to castration-resistant prostate cancer in a mouse xenograft model. Prostate. 2010 Mar 1; 70(4): 390-400. doi: 10.1002/pros.21072 PMID: 19866465
29. Ouyang H, Mou L, Luk C, Liu N, Karaskova J, Squire J, et al. Immortal human pancreatic duct epithelial cell lines with near normal genotype and phenotype. Am J Pathol. 2000 Nov; 157(5): 1623-31. PMID: 11073822
30. Julovi SM, Shen K, McKelvey K, Minhas N, March L, Jackson CJ. Activated Protein C Inhibits Proliferation and Tumour Necrosis Factor alpha-stimulated Activation of p38, JNK and Akt in Rheumatoid Synovial Fibroblasts. Mol Med. 2013 Sep 20.
31. Rye KA, Garrety KH, Barter PJ. Preparation and characterization of spheroidal, reconstituted high-density lipoproteins with apolipoprotein A-I only or with apolipoprotein A-I and A-II. Biochim Biophys Acta. 1993 Apr 23; 1167(3): 316-25. PMID: 8481394
32. Osborne JC Jr. Delipidation of plasma lipoproteins. Methods Enzymol. 1986; 128: 213-22. PMID: 3724503
33. Weisweiler P. Isolation and quantitation of apolipoproteins A-I and A-II from human high-density lipoproteins by fast-protein liquid chromatography. Clin Chim Acta. 1987 Nov 16; 169(2-3): 249-54. PMID: 3123100
34. Julovi SM, Xue M, Dervish S, Sambrook PN, March L, Jackson CJ. Protease activated receptor-2 mediates activated protein cinduced cutaneous wound healing via inhibition of p38. American Journal of Pathology. 2011; 179(5): 2233-42. doi: 10.1016/j.ajpath.2011.07.024 PMID: 21907694
35. Ahmad S, Ahmad A, Schneider KB, White CW. Cholesterol interferes with the MTT assay in human epithelial-like (A549) and endothelial (HLMVE and HCAE) cells. Int J Toxicol. 2006 Jan-Feb; 25(1): 17-23. PMID: 16510353
36. Kim JY, Kim SJ, Jang DJ. Laser-induced shape transformation and electrophoretic analysis of triangular silver nanoplates. J Sep Sci. 2009 Dec; 32(23-24): 4161-6. doi: 10.1002/jssc.200900442 PMID: 20066680
37. Surugau N, Urban PL. Electrophoretic methods for separation of nanoparticles. J Sep Sci. 2009 Jun; 32(11): 1889-906. doi: 10.1002/jssc.200900071 PMID: 19479769
38. Wong MH, Xue A, Julovi SM, Pavlakis N, Samra JS, Hugh TJ, et al. Cotargeting of Epidermal Growth Factor Receptor and PI3K Overcomes PI3K-Akt Oncogenic Dependence in Pancreatic Ductal Adenocarcinoma. Clin Cancer Res. 2014 Aug 1; 20(15): 4047-58. doi: 10.1158/1078-0432.CCR-13-3377 PMID: 24895459
39. Xue A, Julovi SM, Hugh TJ, Samra JS, Wong MH, Gill AJ, et al. A patient-derived subrenal capsule xenograft model can predict response to adjuvant therapy for cancers in the head of the pancreas. Pancreatology. 2015 Jul-Aug; 15(4): 397-404. doi: 10.1016/j.pan.2015.04.008 PMID: 26026767
40. Osborne CK, Hobbs K, Trent JM. Biological differences among MCF-7 human breast cancer cell lines from different laboratories. Breast Cancer Res Treat. 1987; 9(2): 111-21. PMID: 3620713
41. Silva RA, Schneeweis LA, Krishnan SC, Zhang X, Axelsen PH, Davidson WS. The structure of apolipoprotein A-II in discoidal high density lipoproteins. J Biol Chem. 2007 Mar 30; 282(13): 9713-21. PMID: 17264082
42. Kamphorst JJ, Cross JR, Fan J, de Stanchina E, Mathew R, White EP, et al. Hypoxic and Ras-trans-formed cells support growth by scavenging unsaturated fatty acids from lysophospholipids. Proc Natl Acad Sci USA. 2013 May 28; 110(22): 8882-7. doi: 10.1073/pnas.1307237110 PMID: 23671091
43. Commisso C, Davidson SM, Soydaner-Azeloglu RG, Parker SJ, Kamphorst JJ, Hackett S, et al. Macro-pinocytosis of protein is an amino acid supply route in Ras-transformed cells. Nature. 2013 May 30; 497 (7451): 633-7. doi: 10.1038/nature12138 PMID: 23665962
44. Son J, Lyssiotis CA, Ying H, Wang X, Hua S, Ligorio M, et al. Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature. 2013 Apr 4; 496(7443): 101-5. doi: 10.1038/nature12040 PMID: 23535601
45. Papahadjopoulos D, Allen TM, Gabizon A, Mayhew E, Matthay K, Huang SK, et al. Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc Natl Acad Sci USA. 1991 Dec 15; 88(24): 11460-4. PMID: 1763060
46. Gabizon AA Liposomal anthracyclines. Hematol Oncol Clin North Am. 1994 Apr; 8(2): 431-50. PMID: 8040147
47. Gabizon A, Goren D, Horowitz AT, Tzemach D, Lossos A, Siegal T. Long-circulating liposomes for drug delivery in cancer therapy: A review of biodistribution studies in tumor-bearing animals. Advanced Drug Delivery Reviews. 1997 Mar; 24(2-3): 337-44.
48. Daerr WH, Pethke W, Windler ET, Greten H. Biotinyl-high-density lipoproteins as a probe for the determination of high-density lipoprotein turnover in humans. Biochim Biophys Acta. 1990 Apr 17; 1043 (3): 311-7. PMID: 2322574
49. Eisenberg S, Windmueller HG, Levy RI. Metabolic fate of rat and human lipoprotein apoproteins in the rat. J Lipid Res. 1973 Jul; 14(4): 446-58. PMID: 4351783
50. Provenzano PP, Cuevas C, Chang AE, Goel VK, Von Hoff DD, Hingorani SR. Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. Cancer Cell. 2012 Mar 20; 21(3): 418-29. doi: 10.1016/j.ccr.2012.01.007 PMID: 22439937
51. Hidalgo M. Pancreatic cancer. N Engl J Med. 2010 Apr 29; 362(17): 1605-17. doi: 10.1056/NEJMra0901557 PMID: 20427809